Loading: 100%
NUVASIVE INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 1,900 (as per Q2 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker NUVAno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 175060708090
datesClosing price (adj.)
13.10.201750.82
11.10.201750.58
04.10.201755.73
27.09.201756.17
20.09.201753.67
13.09.201758.44
06.09.201761.32
30.08.201761.68
23.08.201763.42
16.08.201767.61
09.08.201763.62
02.08.201764.00
26.07.201779.46
19.07.201780.51
12.07.201778.09
05.07.201776.96
27.06.201775.54
20.06.201777.55
13.06.201778.59
06.06.201778.16
30.05.201775.39
23.05.201772.21
16.05.201773.02
09.05.201771.16
02.05.201773.54
25.04.201776.94
18.04.201772.95
11.04.201772.74
04.04.201773.83
28.03.201775.29
21.03.201774.13
14.03.201774.00
07.03.201774.63
28.02.201774.76
21.02.201773.99
14.02.201774.04
07.02.201771.54
31.01.201770.77
24.01.201769.68
17.01.201769.65
10.01.201769.96
03.01.201766.16
27.12.201666.73
19.12.201667.50
12.12.201667.45
05.12.201665.86
28.11.201664.07
21.11.201664.13
14.11.201660.43
07.11.201659.69
31.10.201659.73
24.10.201667.27
17.10.201666.23
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
50.82n/a
Market Capitalisation
in million USD
2,582n/a
Enterprise Value
in million USD
3,112n/a
Common Shares Outstanding
as per Jul 26, 2017
50,803,820n/a
Preferred Shares Outstanding
as per Jul 26, 2017
n/a
Average Basic Shares Outstanding
TTM
50,578,500n/a
Average Diluted Shares Outstanding
TTM
57,437,500n/a
Index Membership
n/a
Business Summary
NuVasive Inc is a medical device company. It develops minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its product portfolio is focused on applications for spine fusion surgery.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 1,021n/a
Gross Profit 767n/a
Operating Income 116n/a
EBITDA 231n/a
Net Profit 36n/a
Balance Sheet
Cash and Cash Equivalents 131n/a
Receivables 190n/a
Total Current Assets 592n/a
PP&E 215n/a
Total Assets 1,606n/a
Accounts Payable 0n/a
Current Debt 83n/a
Total Current Liabilities 247n/a
Long-Term Debt 574n/a
Total Liabilities 883n/a
Total Equity 724n/a
Cash Flow
Depreciation & Amortisation 115n/a
Change in Working Capital -110n/a
Operating Cash Flow 123n/a
Net Change in PP&E and Intangibles -106n/a
Investing Cash Flow -229n/a
Dividends Paid 0n/a
Financing Cash Flow -26n/a
Total Change in Cash -132n/a
Free Cash Flow -13n/a
Profitability Ratios
Gross Margin 75.1%n/a
Operating Margin 11.3%n/a
Net Profit Margin 3.3%n/a
Return on Equity 4.7%n/a
Return on Assets 2.1%n/a
Per Share Figures
Basic EPS 0.71n/a
Diluted EPS 0.62n/a
Sales per Share 20.19n/a
Book Value per Share 14.21n/a
FCF per Share -0.25n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 71.94n/a
Price to Sales Ratio 2.52n/a
Price to Book Value 3.55n/a
Price to Free Cash Flow -205.62n/a
Valuation Metrics
EV/EBITDA 13.49n/a
EV/Sales 3.05n/a
Book to Market Value 0.28n/a
Other Ratios
Current Ratio 239.9%n/a
Liabilities to Equity Ratio 122.0%n/a
Debt to Assets Ratio 40.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
250
370
478
541
620
685
762
811
962
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-39
-61
-85
-112
-153
-180
-182
-194
-240
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
211
309
393
428
467
505
580
617
722
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-218
-298
-361
-394
-420
-472
-508
-506
-624
Selling, General & Administrative
-189
-255
-315
-349
-372
-420
-457
-457
-534
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-26
-38
-41
-38
-35
-32
-37
-36
-48
Depreciation & Amortization
-3
-5
-5
-7
-12
-19
-14
-13
-42
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
-7
11
32
34
47
33
72
111
98
Non-Operating Income (Loss)
0
-5
-6
-15
-26
-23
-29
-27
-40
Interest Expense, net
0
-6
-6
-17
-27
-26
-27
-27
-39
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
2
1
3
-2
0
0
Pretax Income (Loss), Adjusted
-7
6
26
19
21
10
43
84
59
Abnormal Gains (Losses)
-21
0
0
-119
-10
0
-54
28
6
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-28
6
26
-100
11
10
-11
112
65
Income Tax (Expense) Benefit, net
0
-2
51
29
-9
-3
-6
-47
-29
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-28
4
77
-71
2
7
-17
65
35
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-28
4
77
-71
2
7
-17
65
35
Minority Interest
0
1
2
1
1
1
1
1
2
Net Income
-28
6
78
-70
3
8
-17
66
37
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-28
6
78
-70
3
8
-17
66
37
Remarks
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Feb 25, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
165
179
310
262
246
363
358
154
Cash & Cash Equivalents
n/a
65
93
163
123
103
142
192
154
Short Term Investments
n/a
99
86
146
138
143
220
165
0
Accounts & Notes Receivable
n/a
58
74
88
89
105
119
128
172
Accounts Receivable, Net
n/a
58
74
88
89
105
119
128
172
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
90
108
119
126
137
155
168
208
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
4
11
75
37
48
22
49
42
Prepaid Expenses
n/a
4
6
21
8
11
10
9
10
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
4
55
28
37
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
11
41
32
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
Total Current Assets
n/a
317
372
592
514
536
658
703
575
Property, Plant & Equipment, Net
n/a
83
102
125
125
128
129
141
182
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
40
51
33
84
80
43
112
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
213
277
374
441
436
512
346
814
Intangible Assets
n/a
103
107
108
101
94
97
85
291
Goodwill
n/a
102
103
159
154
155
154
154
486
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
1
52
20
41
43
111
84
6
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
7
15
87
144
144
150
23
31
Total Noncurrent Assets
n/a
336
430
532
650
644
684
600
995
Total Assets
n/a
653
802
1,124
1,164
1,180
1,342
1,303
1,571
Liabilities and owners' equity
Payables & Accruals
n/a
55 54747000
76 76261000
74 73959000
90 89964000
117 117152000
184 184096000
100 99616000
131 131054000
Accounts Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
55 54747000
76 76261000
74 73959000
90 89964000
117 117152000
184 184096000
100 99616000
131 131054000
Short Term Debt
n/a
0 0
0 0
0 0
74 74311000
0 0
0 0
0 0
62 61701000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
31 30694000
33 33041000
133 133421000
0 0
0 0
30 30000000
0 0
50 49742000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
31 30694000
33 33041000
133 133421000
0 0
0 0
30 30000000
0 0
50 49742000
Total Current Liabilities
n/a
85 85441000
109 109302000
207 207380000
164 164275000
117 117152000
214 214096000
100 99616000
242 242497000
Long Term Debt
n/a
230 230000000
230 230000000
394 394019000
332 332404000
346 346060000
361 360746000
373 372920000
564 564412000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
28 27528000
16 16495000
17 17413000
120 119528000
111 111478000
118 118371000
111 111288000
63 63371000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
17 16756000
4 3685000
4 3952000
3 3129000
3 2934000
11 11441000
9 8602000
19 18607000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
11 10772000
13 12810000
13 13461000
116 116399000
109 108544000
107 106930000
103 102686000
45 44764000
Total Noncurrent Liabilities
n/a
258 257528000
246 246495000
411 411432000
452 451932000
458 457538000
479 479117000
484 484208000
628 627783000
Total Liabilities
n/a
343 342969000
356 355797000
619 618812000
616 616207000
575 574690000
693 693213000
584 583824000
870 870280000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
486 485796000
545 545154000
675 674832000
715 714909000
769 769248000
847 847193000
989 989440000
1,010 1010293000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
-11 -10537000
-162 -161788000
-238 -237867000
Retained Earnings
n/a
-190 -189700000
-111 -111415000
-181 -181264000
-178 -178120000
-170 -170218000
-187 -186938000
-104 -104006000
-67 -66859000
Other Equity
n/a
0 126000
1 616000
0 477000
1 786000
-3 -3238000
-10 -9670000
-12 -12112000
-11 -10631000
Equity Before Minority Interest
n/a
296 296222000
434 434355000
494 494045000
538 537575000
596 595792000
640 640048000
712 711534000
695 694936000
Minority Interest
n/a
14 13629000
12 11877000
11 10705000
10 10003000
9 9086000
8 8310000
7 7309000
6 5588000
Total Equity
n/a
310 309851000
446 446232000
505 504750000
548 547578000
605 604878000
648 648358000
719 718843000
701 700524000
Total Liabilities & Equity
n/a
653 652820000
802 802029000
1,124 1123562000
1,164 1163785000
1,180 1179568000
1,342 1341571000
1,303 1302667000
1,571 1570804000
Remarks restated on n/a restated on Feb 25, 2011 n/a restated on Feb 27, 2012 n/a restated on Feb 27, 2013 n/a restated on Mar 3, 2014 n/a restated on Feb 25, 2015 n/a restated on Feb 11, 2016 n/a restated on Feb 9, 2017 n/a restated on Jul 27, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-28
4
77
-71
2
7
-17
65
35
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
23
30
37
36
52
63
66
66
103
Non-Cash Items
47
30
-19
39
68
52
53
106
123
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-47
-18
-29
59
8
-24
15
-148
-105
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
-5
46
66
63
130
97
116
89
156
Change in Fixed Assets & Intangibles
-40
-33
-46
-58
-41
-59
-58
-108
-94
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-63
-49
1
-106
-103
-2
-46
-79
278
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-41
-46
-1
-38
-11
-3
0
0
-380
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-14
0
0
-32
7
0
-1
179
-564
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-159
-128
-46
-234
-148
-65
-105
-8
-761
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
222
0
0
391
0
-74
0
0
584
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
12
13
15
7
5
8
20
-45
-15
Increase in Capital Stock
12
13
15
7
5
8
23
12
9
Decrease in Capital Stock
0
0
0
0
0
0
-4
-57
-25
Other Financing Activities
0
2
-8
-156
-27
13
11
14
-2
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
234
14
7
242
-23
-52
30
-30
567
Net Cash Before Disc. Operations and FX
70
-67
27
71
-40
-20
41
51
-38
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
70
-67
27
71
-40
-20
41
51
-38
Effect of Foreign Exchange Rates
0
0
0
0
0
-1
-1
-1
-1
Net Changes in Cash
70
-67
27
71
-40
-20
40
50
-39
Remarks
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Feb 25, 2015 n/a
calculated values,
restated on Feb 11, 2016 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
restated on Feb 9, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo